Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q1 2024)
As of Mar 31, 2024, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 13, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q1 2024, the filing reported:
New Buys - AAON, Inc., Abbott Laboratories, Aurora Cannabis Inc., ACM Research, Inc., Acrivon Therapeutics, Inc., and 527 more
Increases - NeuBase Therapeutics, Goldman Sachs Physical Gold ETF, Aadi Bioscience, Inc., Atlantic American Corporation, , and 1370 more
Reductions - Alcoa Corporation, American Airlines Group, Inc., Advance Auto Parts Inc., Apple Inc., AbbVie Inc., and 1345 more
Complete Exits - Applied Optoelectronics, Inc., Arcosa, Inc., Arcellx, Inc., Automatic Data Processing, Inc., ADT Inc., and 412 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q1 2024
|
64132K201
NeuBase Therapeutics
|
Buy |
+31,262
|
|
Q1 2024
|
AA
Alcoa Corporation
|
Sell |
-102,400
|
|
Q1 2024
|
AAAU
Goldman Sachs Physical Gold ETF
|
Buy |
+88,800
|
|
Q1 2024
|
AADI
Aadi Bioscience, Inc.
|
Buy |
+145,000
|
|
Q1 2024
|
AAL
American Airlines Group, Inc.
|
Sell |
-3,301,632
|
|
Q1 2024
|
AAME
Atlantic American Corporation
|
Buy |
+1,200
|
|
Q1 2024
|
Buy |
+48,000
|
|
|
Q1 2024
|
AAOI
Applied Optoelectronics, Inc.
|
Sell - Position Exit |
-26,400
|
|
Q1 2024
|
AAON
AAON, Inc.
|
Buy - Position Entry |
+37,635
|
|
Q1 2024
|
AAP
Advance Auto Parts Inc.
|
Sell |
-350,400
|
|
Q1 2024
|
AAPL
Apple Inc.
|
Sell |
-1,846,530
|
|
Q1 2024
|
AAT
American Assets Trust, Inc.
|
Buy |
+77,100
|
|
Q1 2024
|
AAXJ
iShares MSCI All Country Asia e
|
Buy |
+14,500
|
|
Q1 2024
|
ABBV
AbbVie Inc.
|
Sell |
-867,717
|
|
Q1 2024
|
ABCL
AbCellera Biologics Inc.
|
Buy |
+30,100
|
|
Q1 2024
|
ABEO
Abeona Therapeutics Inc.
|
Sell |
-108,556
|
|
Q1 2024
|
ABEV
Ambev S.A.
|
Buy |
+6,191,954
|
|
Q1 2024
|
Buy |
+8,400
|
|
|
Q1 2024
|
ABM
ABM Industries Incorporated
|
Sell |
-69,600
|
|
Q1 2024
|
ABNB
Airbnb, Inc.
|
Buy |
+127,665
|
|
Q1 2024
|
ABSI
Absci Corporation
|
Sell |
-300
|
|
Q1 2024
|
ABT
Abbott Laboratories
|
Buy - Position Entry |
+836,766
|
|
Q1 2024
|
AC
Associated Capital Group, Inc.
|
Buy |
+3,597
|
|
Q1 2024
|
ACA
Arcosa, Inc.
|
Sell - Position Exit |
-11,915
|
|
Q1 2024
|
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
+389,800
|
|
Q1 2024
|
ACB
Aurora Cannabis Inc.
|
Buy - Position Entry |
+879,670
|
|
Q1 2024
|
ACCD
Accolade, Inc.
|
Buy |
+25,400
|
|
Q1 2024
|
ACCO
Acco Brands Corporation
|
Buy |
+6,300
|
|
Q1 2024
|
ACDC
ProFrac Holding Corp.
|
Buy |
+30,199
|
|
Q1 2024
|
ACEL
Accel Entertainment, Inc.
|
Sell |
-121,600
|
Page 1 of 123